COX7A1
gene geneOn this page
Also known as COX7AH
Summary
COX7A1 (cytochrome c oxidase subunit 7A1, HGNC:2287) is a protein-coding gene on chromosome 19q13.12, encoding Cytochrome c oxidase subunit 7A1, mitochondrial (P24310). Component of the mitochondrial respiratory complex IV (CIV, also named cytochrome c oxidase complex), the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation.
Cytochrome c oxidase (COX), the terminal component of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. This component is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in electron transfer, and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes polypeptide 1 (muscle isoform) of subunit VIIa and the polypeptide 1 is present only in muscle tissues. Other polypeptides of subunit VIIa are present in both muscle and nonmuscle tissues, and are encoded by different genes.
Source: NCBI Gene 1346 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 24 total
- MANE Select transcript:
NM_001864
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:2287 |
| Approved symbol | COX7A1 |
| Name | cytochrome c oxidase subunit 7A1 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | COX7AH |
| Ensembl gene | ENSG00000161281 |
| Ensembl biotype | protein_coding |
| OMIM | 123995 |
| Entrez | 1346 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron
ENST00000292907, ENST00000437291, ENST00000481297, ENST00000589154
RefSeq mRNA: 1 — MANE Select: NM_001864
NM_001864
CCDS: CCDS12490
Canonical transcript exons
ENST00000292907 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001057391 | 36152393 | 36152447 |
| ENSE00003514987 | 36151669 | 36151755 |
| ENSE00003684500 | 36151462 | 36151546 |
| ENSE00003700794 | 36150922 | 36151034 |
Expression profiles
Bgee: expression breadth ubiquitous, 276 present calls, max score 99.96.
FANTOM5 (CAGE): breadth broad, TPM avg 14.4040 / max 932.8178, expressed in 851 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180658 | 13.7906 | 826 |
| 208792 | 0.4785 | 25 |
| 180660 | 0.1349 | 55 |
Top tissues by expression
290 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| heart right ventricle | UBERON:0002080 | 99.96 | gold quality |
| apex of heart | UBERON:0002098 | 99.92 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 99.91 | gold quality |
| diaphragm | UBERON:0001103 | 99.90 | gold quality |
| cardiac ventricle | UBERON:0002082 | 99.89 | gold quality |
| heart left ventricle | UBERON:0002084 | 99.89 | gold quality |
| cardiac atrium | UBERON:0002081 | 99.88 | gold quality |
| right atrium auricular region | UBERON:0006631 | 99.88 | gold quality |
| biceps brachii | UBERON:0001507 | 99.86 | gold quality |
| myocardium | UBERON:0002349 | 99.86 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 99.86 | gold quality |
| vastus lateralis | UBERON:0001379 | 99.85 | gold quality |
| gastrocnemius | UBERON:0001388 | 99.85 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 99.85 | gold quality |
| quadriceps femoris | UBERON:0001377 | 99.83 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 99.82 | gold quality |
| triceps brachii | UBERON:0001509 | 99.81 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 99.81 | gold quality |
| gluteal muscle | UBERON:0002000 | 99.79 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 99.77 | gold quality |
| body of tongue | UBERON:0011876 | 99.75 | gold quality |
| heart | UBERON:0000948 | 99.69 | gold quality |
| vena cava | UBERON:0004087 | 99.60 | gold quality |
| muscle organ | UBERON:0001630 | 99.53 | gold quality |
| muscle tissue | UBERON:0002385 | 99.52 | gold quality |
| muscle of leg | UBERON:0001383 | 99.42 | gold quality |
| tibialis anterior | UBERON:0001385 | 99.39 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 99.35 | gold quality |
| deltoid | UBERON:0001476 | 99.33 | gold quality |
| popliteal artery | UBERON:0002250 | 99.33 | gold quality |
Single-cell (SCXA)
Detected in 10 experiment(s), a significant marker in 8.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-79 | yes | 609.09 |
| E-MTAB-6701 | yes | 114.87 |
| E-HCAD-1 | yes | 77.12 |
| E-MTAB-10287 | yes | 47.89 |
| E-MTAB-8410 | yes | 25.85 |
| E-CURD-46 | yes | 10.15 |
| E-GEOD-84465 | yes | 8.69 |
| E-MTAB-7037 | no | 142.21 |
| E-MTAB-8060 | no | 110.51 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): MEF2A, TRPV4
Literature-anchored findings (GeneRIF, showing 7)
- promoter contains and is regulated by sequence elements typical of contractile muscle as well as the element for the common transcription factor Sp1 (PMID:11997101)
- While DNA methylation of the COX7A1 promoter was increased in muscle from elderly compared with young twins, the opposite was found for COX7A1 mRNA expression (PMID:18488190)
- Data found that subunits Cox6a, Cox6b and Cox7a assembled into pre-existing complex IV, while Cox4-1 and Cox6c subunits assembled into subcomplexes that may represent rate-limiting intermediates. (PMID:19843159)
- We demonstrate a developmental isoform switch of COX6A and COX7A subunits in human and mouse skeletal muscle (PMID:25666558)
- COX7A1 is a novel gene that might play a crucial role in the etiology of lung adenocarcinoma and can serve as a biomarker for lung cancer disease progression (PMID:27866983)
- COX7A1 enhances the sensitivity of human NSCLC cells to cystine deprivation-induced ferroptosis via regulating mitochondrial metabolism. (PMID:36418320)
- Overexpression of COX7A1 Promotes the Resistance of Gastric Cancer to Oxaliplatin and Weakens the Efficacy of Immunotherapy. (PMID:38830579)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cox7a1 | ENSMUSG00000074218 |
| rattus_norvegicus | Cox7a1 | ENSRNOG00000076290 |
| drosophila_melanogaster | COX7AL | FBGN0037579 |
| drosophila_melanogaster | COX7AL2 | FBGN0085201 |
Paralogs (2): COX7A2 (ENSG00000112695), COX7A2L (ENSG00000115944)
Protein
Protein identifiers
Cytochrome c oxidase subunit 7A1, mitochondrial — P24310 (reviewed: P24310)
Alternative names: Cytochrome c oxidase subunit VIIa-heart, Cytochrome c oxidase subunit VIIa-muscle
All UniProt accessions (4): P24310, K7ER11, Q6FGI7, U3KQH8
UniProt curated annotations — full annotation on UniProt →
Function. Component of the mitochondrial respiratory complex IV (CIV, also named cytochrome c oxidase complex), the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The CIV complex is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Acts as an assembly factor that specifically drives the homodimerization of CIV complexes, mediating the formation of mitochondrial respiratory supercomplexes (respirasomes) containing two CIV: supercomplxes with two molecules of CIV show improved activity. Despite being highly expressed in brown adipose tissue, not required for thermogenesis.
Subunit / interactions. Component of the complex IV (CIV, cytochrome c oxidase), a multisubunit enzyme composed of 14 subunits. The complex is composed of a catalytic core of 3 subunits MT-CO1, MT-CO2 and MT-CO3, encoded in the mitochondrial DNA, and 11 supernumerary subunits COX4I1 (or COX4I2), COX5A, COX5B, COX6A2 (or COX6A1), COX6B1 (or COX6B2), COX6C, COX7A1 (or COX7A2), COX7B, COX7C, COX8B and COXFA4, which are encoded in the nuclear genome. The complex exists as a monomer or a dimer and forms supercomplexes (SCs) in the inner mitochondrial membrane with NADH-ubiquinone oxidoreductase (complex I, CI) and ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII), resulting in different assemblies (supercomplex SCI(1)III(2)IV(1) and megacomplex MCI(2)III(2)IV(2)).
Subcellular location. Mitochondrion inner membrane.
Pathway. Energy metabolism; oxidative phosphorylation.
Similarity. Belongs to the cytochrome c oxidase VIIa family.
RefSeq proteins (1): NP_001855* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003177 | Cytc_oxidase_su7a_met | Family |
| IPR036539 | Cyt_c_oxidase_su7a_sf | Homologous_superfamily |
| IPR039297 | COX7a | Family |
Pfam: PF02238
UniProt features (5 total): topological domain 2, transit peptide 1, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P24310-F1 | 88.43 | 0.68 |
Function
Pathways and Gene Ontology
Reactome pathways
5 pathways
| ID | Pathway |
|---|---|
| R-HSA-5628897 | TP53 Regulates Metabolic Genes |
| R-HSA-611105 | Respiratory electron transport |
| R-HSA-9707564 | Cytoprotection by HMOX1 |
| R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 |
| R-HSA-9864848 | Complex IV assembly |
MSigDB gene sets: 205 (showing top):
MODULE_93, YAGI_AML_WITH_INV_16_TRANSLOCATION, ENK_UV_RESPONSE_KERATINOCYTE_UP, GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY, GNF2_MYL3, TANG_SENESCENCE_TP53_TARGETS_UP, GOBP_MONOATOMIC_CATION_TRANSPORT, FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, MODULE_66, GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY, PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP, MCBRYAN_PUBERTAL_BREAST_4_5WK_DN, GOBP_OXIDATIVE_PHOSPHORYLATION, WONG_ENDMETRIUM_CANCER_DN, GOBP_ELECTRON_TRANSPORT_CHAIN
GO Biological Process (5): generation of precursor metabolites and energy (GO:0006091), oxidative phosphorylation (GO:0006119), mitochondrial electron transport, cytochrome c to oxygen (GO:0006123), mitochondrial respirasome assembly (GO:0097250), proton transmembrane transport (GO:1902600)
GO Molecular Function (3): cytochrome-c oxidase activity (GO:0004129), oxidoreductase activity (GO:0016491), protein binding (GO:0005515)
GO Cellular Component (6): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial membrane (GO:0031966), respiratory chain complex IV (GO:0045277), respiratory chain complex (GO:0098803), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Transcriptional Regulation by TP53 | 1 |
| Aerobic respiration and respiratory electron transport | 1 |
| Cellular response to chemical stress | 1 |
| Transcriptional regulation of brown and beige adipocyte differentiation | 1 |
| Respiratory electron transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| metabolic process | 1 |
| aerobic respiration | 1 |
| proton motive force-driven ATP synthesis | 1 |
| aerobic electron transport chain | 1 |
| mitochondrial ATP synthesis coupled electron transport | 1 |
| mitochondrion organization | 1 |
| mitochondrial respiratory chain complex assembly | 1 |
| monoatomic cation transmembrane transport | 1 |
| electron transfer activity | 1 |
| proton transmembrane transporter activity | 1 |
| oxidoreduction-driven active transmembrane transporter activity | 1 |
| oxidoreductase activity, acting on a heme group of donors | 1 |
| active monoatomic ion transmembrane transporter activity | 1 |
| catalytic activity | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| mitochondrion | 1 |
| mitochondrial envelope | 1 |
| organelle membrane | 1 |
| cytochrome complex | 1 |
| respiratory chain complex | 1 |
| transmembrane transporter complex | 1 |
| oxidoreductase complex | 1 |
| protein-containing complex | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1036 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| COX7A1 | COX6B1 | P14854 | 952 |
| COX7A1 | UQCRC1 | P31930 | 945 |
| COX7A1 | UQCR11 | O14957 | 932 |
| COX7A1 | COX6A2 | Q02221 | 886 |
| COX7A1 | COX5B | P10606 | 883 |
| COX7A1 | COX6A1 | P12074 | 870 |
| COX7A1 | UQCRB | P14927 | 799 |
| COX7A1 | CIDEA | O60543 | 788 |
| COX7A1 | COX7C | P15954 | 764 |
| COX7A1 | COXFA4 | O00483 | 763 |
| COX7A1 | COX4I2 | Q96KJ9 | 731 |
| COX7A1 | COX5A | P20674 | 728 |
| COX7A1 | COX4I1 | P13073 | 725 |
| COX7A1 | FXYD5 | Q96DB9 | 722 |
| COX7A1 | UCP1 | P25874 | 721 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NDUFS1 | COX7A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLF11 | COX7A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUP58 | COX7A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DNAJB6 | COX7A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| COX7A1 | GLS | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (13): PLGRKT (Affinity Capture-MS), GLS (Affinity Capture-MS), UBR1 (Affinity Capture-MS), COX6C (Affinity Capture-MS), COX4I1 (Affinity Capture-MS), POLG (Affinity Capture-MS), COX6B1 (Affinity Capture-MS), COX2 (Affinity Capture-MS), COX3 (Affinity Capture-MS), COX1 (Affinity Capture-MS), COX5B (Affinity Capture-MS), PFDN1 (Cross-Linking-MS (XL-MS)), TCERG1 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A1XQS2, A4IJ20, F6QZ15, O14548, O60397, P0CU26, P13183, P14406, P24310, P34660, P46269, P56392, Q0V9J0, Q17ED3, Q290M9, Q2KI08, Q2M2S2, Q3T061, Q4QQV3, Q4R6H1, Q4VC39, Q5R504, Q5RE99, Q5REP2, Q5XIJ4, Q5XKA2, Q5ZML6, Q61387, Q64445, Q7JX57, Q7QHP6, Q7SXI1, Q7Z4L0, Q8BGY7, Q8BTC1, Q91W29, Q91Y94, Q99KD6, Q9BUB7, Q9BVV7
Diamond homologs: O14548, O60397, P07470, P13184, P14406, P24310, P35171, P48771, P56392, Q08CE7, Q3T061, Q53CF6, Q61387, Q7SXI1, Q8SPJ9, Q99KD6, Q9N234, Q9TR29, Q9VHS2, Q9TR28, Q9TR30, Q9TRZ8, P80333
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 15 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
500 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:36151680:T:TA | donor_gain | 1.0000 |
| 19:36151460:ACCG:A | donor_gain | 0.9900 |
| 19:36151460:ACCGC:A | donor_gain | 0.9900 |
| 19:36151461:CCG:C | donor_gain | 0.9900 |
| 19:36151461:CCGC:C | donor_gain | 0.9900 |
| 19:36151461:CCGCC:C | donor_gain | 0.9900 |
| 19:36151487:TCGG:T | donor_gain | 0.9900 |
| 19:36151694:A:AC | donor_gain | 0.9900 |
| 19:36151695:C:CC | donor_gain | 0.9900 |
| 19:36151455:CGCT:C | donor_loss | 0.9800 |
| 19:36151456:GCTC:G | donor_loss | 0.9800 |
| 19:36151458:T:TC | donor_loss | 0.9800 |
| 19:36151459:C:CC | donor_loss | 0.9800 |
| 19:36151460:A:AC | donor_gain | 0.9800 |
| 19:36151461:C:CC | donor_gain | 0.9800 |
| 19:36151488:CGGT:C | donor_gain | 0.9800 |
| 19:36151756:CTGCG:C | acceptor_loss | 0.9800 |
| 19:36151544:CTC:C | acceptor_gain | 0.9700 |
| 19:36151547:C:CC | acceptor_gain | 0.9700 |
| 19:36151753:CAC:C | acceptor_gain | 0.9700 |
| 19:36152386:GCCTC:G | donor_loss | 0.9600 |
| 19:36152387:CCTCA:C | donor_loss | 0.9600 |
| 19:36152388:CTCA:C | donor_loss | 0.9600 |
| 19:36152389:TCA:T | donor_loss | 0.9600 |
| 19:36152390:CACCC:C | donor_loss | 0.9600 |
| 19:36152391:AC:A | donor_gain | 0.9600 |
| 19:36152392:CC:C | donor_gain | 0.9600 |
| 19:36152439:C:A | donor_gain | 0.9600 |
| 19:36151474:G:C | donor_gain | 0.9500 |
| 19:36152411:G:A | donor_gain | 0.9400 |
AlphaMissense
505 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:36151021:G:C | S67R | 0.983 |
| 19:36151021:G:T | S67R | 0.983 |
| 19:36151023:T:G | S67R | 0.983 |
| 19:36151517:C:A | K44N | 0.973 |
| 19:36151517:C:G | K44N | 0.973 |
| 19:36151672:G:C | F33L | 0.973 |
| 19:36151672:G:T | F33L | 0.973 |
| 19:36151674:A:G | F33L | 0.973 |
| 19:36151681:C:A | Q30H | 0.961 |
| 19:36151681:C:G | Q30H | 0.961 |
| 19:36151673:A:C | F33C | 0.957 |
| 19:36151465:C:G | G62R | 0.947 |
| 19:36151464:C:T | G62D | 0.945 |
| 19:36151471:A:G | C60R | 0.930 |
| 19:36151673:A:G | F33S | 0.929 |
| 19:36151503:T:A | D49V | 0.928 |
| 19:36151502:G:C | D49E | 0.927 |
| 19:36151502:G:T | D49E | 0.927 |
| 19:36151462:C:G | G63R | 0.923 |
| 19:36151034:C:T | G63D | 0.920 |
| 19:36151521:A:G | L43P | 0.920 |
| 19:36151669:C:A | Q34H | 0.919 |
| 19:36151669:C:G | Q34H | 0.919 |
| 19:36151518:T:A | K44M | 0.918 |
| 19:36151518:T:G | K44T | 0.918 |
| 19:36151504:C:G | D49H | 0.911 |
| 19:36151729:G:C | F14L | 0.910 |
| 19:36151729:G:T | F14L | 0.910 |
| 19:36151731:A:G | F14L | 0.910 |
| 19:36151503:T:G | D49A | 0.909 |
dbSNP variants (sampled 300 via entrez): RS1000585096 (19:36152850 C>G,T), RS1000617632 (19:36152663 G>T), RS1002351480 (19:36152059 G>T), RS1003165174 (19:36153589 G>A), RS1003994734 (19:36151031 G>A), RS1004487313 (19:36154446 C>T), RS1004851907 (19:36153006 T>C), RS1004874128 (19:36153872 A>T), RS1005886213 (19:36152336 G>A), RS1008534287 (19:36154204 T>C), RS1008717833 (19:36154254 A>G), RS1010930947 (19:36151345 C>G,T), RS1010962214 (19:36151071 A>G), RS1011754945 (19:36153255 C>A,G,T), RS1012184648 (19:36150640 A>G)
Disease associations
OMIM: gene MIM:123995 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002592_32 | Neuritic plaque | 6.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006798 | neuritic plaque measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| JP8 aviation fuel | decreases expression | 1 |
| bisphenol S | increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Acetaminophen | affects cotreatment, decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Dexamethasone | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Nickel | decreases expression | 1 |
| Progesterone | decreases expression | 1 |
| Selenium | decreases expression | 1 |
| Triclosan | decreases expression | 1 |
| Valproic Acid | decreases expression, increases methylation | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | increases expression | 1 |
| Zidovudine | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.